1. lncRNA PDIA3P regulates cell proliferation and invasion in non‑small cell lung cancer
   Xiaogang Yang et al, 2019, Experimental and Therapeutic Medicine CrossRef
2. Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer
   Zongbin Xu et al, 2016, Experimental and Therapeutic Medicine CrossRef
3. HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer
   Hai Luo et al, 2021, Cancer Management and Research CrossRef
4. Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib
   Ines De Pauw et al, 2019, Cancers CrossRef
5. Utility of Serial Transcriptomic Analyses to Characterize the Resistome and to Refine Treatment Selection for Metastatic Colon Cancer: Case Report
   Michael P. Castro et al, 2021, Clinical Colorectal Cancer CrossRef
6. Evaluation of human epidermal growth factor receptor 2 expression in colorectal cancer and its correlation with clinicopathological variables
   Sana Ahuja et al, 2021, Journal of Mahatma Gandhi Institute of Medical Sciences CrossRef
7. Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
   Shujuan Ni et al, 2022, Frontiers in Oncology CrossRef
8. Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status
   Ozkan Kanat et al, 2018, World Journal of Clinical Cases CrossRef
9. HER2aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
   Nicola Fusco et al, 2016, World Journal of Gastroenterology CrossRef
10. HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer
    Mi Jung Kwon et al, 2019, Pathology - Research and Practice CrossRef
11. STUDY OF HER2 NEU POSITIVITY IN GASTROINTESTINAL CANCERS AT A TERTIARY CARE HOSPITAL IN INDIA
    Ritu Jangir et al, 2021, INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH CrossRef
12. Differences in Extracellular Vesicle Protein Cargo Are Dependent on Head and Neck Squamous Cell Carcinoma Cell of Origin and Human Papillomavirus Status
    Christine Goudsmit et al, 2021, Cancers CrossRef
13. HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
    Valentina Fanotto et al, 2016, Oncotarget CrossRef
14. Assessment of a HER2 scoring system for colorectal cancer: results from a validation study
    Emanuele Valtorta et al, 2015, Modern Pathology CrossRef
15. Heterogeneous clinical and pathological landscapes of HER2 positive colorectal cancer
    Zhiqin Chen et al, 2021, Expert Review of Anticancer Therapy CrossRef
16. Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
    Nannan Wang et al, 2022, Cancers CrossRef